multi-cancer early detection

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test. 

Precision Medicine Online readers were interested in stories about implementation challenges in the space, the first cell therapies for solid tumors, and cardiovascular drugs targeting Lp(a).

The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer.